SCHEMBL1415580

SCHEMBL1415580

Cc1ccc2c(c1)c(=O)c1cc3c(cc1n2CCCCCC(=O)O)c(=O)c1cc(C)ccc1n3CCCCCC(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.55
POLB P06746 1/20 0.55
HSD17B10 Q99714 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
FABP4 P15090 2/20 0.54
FABP5 Q01469 2/20 0.54
SMN1; SMN2 Q16637 4/20 0.50
MAPT P10636 4/20 0.50
RXFP1 Q9HBX9 2/20 0.50
THRB P10828 1/20 0.50
TP53 P04637 3/20 0.48
CSF1R P07333 1/20 0.48
MARK4 Q96L34 2/20 0.46
PGR P06401 1/20 0.43
RORA P35398 1/20 0.43
RORC P51449 1/20 0.43
RORB Q92753 1/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
TBXAS1 P24557 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31305276 0.90 FABP4 (0.60) KDM4EPOLBHSD17B10L3MBTL1FABP4
SCHEMBL14266804 0.85 SMN1; SMN2 (0.47) KDM4EPOLBHSD17B10L3MBTL1SMN1; SMN2
SCHEMBL1415661 0.84 FABP4 (0.54) FABP4FABP5SMN1; SMN2MAPTRXFP1
SCHEMBL1415590 0.84 FABP4 (0.54) FABP4FABP5MAPTTP53TBXAS1
SCHEMBL1415451 0.84 FABP4 (0.54) KDM4EFABP4FABP5SMN1; SMN2RXFP1
SCHEMBL1415605 0.84 MAOA (0.51) KDM4EHSD17B10FABP4FABP5ALDH1A1
SCHEMBL16786336 0.83 RORA (0.57) SMN1; SMN2MAPTRXFP1THRBTP53
SCHEMBL355687 0.81 FABP4 (0.56) KDM4EFABP4FABP5SMN1; SMN2RXFP1
SCHEMBL1415802 0.81 FABP4 (0.64) FABP4FABP5SMN1; SMN2MAPTTP53
SCHEMBL13471984 0.80 RORA (0.59) SMN1; SMN2MAPTRXFP1THRBTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1399742-B1 QUINACRIDONE LABELLING REAGENTS FOR FLUORESCENCE DETECTION OF BIOLOGICAL MATERIALS GE HEALTHCARE UK LTD (GB) 2011-03-16 EP disclosed
US-7335771-B2 Quinacridone derivatives as labelling reagents for fluorescence detection of biological materials GE HEALTHCARE UK LIMITED (GB) 2008-02-26 US disclosed
US-20040171014-A1 Quinacridone derivatives as labelling reagents for flurescence detection of bilogical materials TTP LABTECH LIMITED (GB) 2004-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040171014-A1 Quinacridone derivatives as labelling reagents for flurescence detection of bilogical materials Q6ZSR9, MPHOSPH6, NQO2 KDM4E 3505/4885POLB 2686/4885HSD17B10 2383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.